Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-003821

Options or other derivatives

  • Director returned 1,281 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Karah Hila · Director

Table II: Derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-10 Returned to the company : show line 1 in the form Stock Option (right to buy) −500 $0.39 $195 0 D
2025-04-10 Returned to the company : show line 2 in the form Stock Option (right to buy) −250 $0.39 $98 0 D
2025-04-10 Returned to the company : show line 3 in the form Stock Option (right to buy) −281 $0.39 $110 0 D
2025-04-10 Returned to the company : show line 4 in the form Stock Option (right to buy) −250 $0.39 $98 0 D
Loading xslF345X05/ownership.xml…